Celldex Therapeutics Inc (NASDAQ:CLDX)

23.71
Data as of Jan 27
 +0.47 / +2.02%
Today’s Change
10.76
Today|||52-Week Range
33.33
+29.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues46.8M9.3M11.2M4.1M
 
 
 
 
 
 
Operating ExpensesGross Income1.2M-1.8M-663.0K-1.2M
 
 
 
 
 
Total Operating Expenses53.3M52.7M69.3M85.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.5M-43.4M-58.1M-81.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.5M-44.8M-59.1M-81.6M
 
 
 
 
 
Net Income-2.5M-44.8M-59.1M-81.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.9M39.5M57.7M79.8M
 
 
 
 
 
Shares To Calculate EPS Diluted31.9M39.5M57.7M79.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$1.13-$1.02-$1.02
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.